Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy-Reference-Cited by-同舟云学术

Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy

Published:2009-05-14 Issue:5 Volume:4 Page:e5268
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Swoboda Kathryn J.,Scott Charles B.,Reyna Sandra P.,Prior Thomas W.,LaSalle Bernard,Sorenson Susan L.,Wood Janine,Acsadi Gyula,Crawford Thomas O.,Kissel John T.,Krosschell Kristin J.,D'Anjou Guy,Bromberg Mark B.,Schroth Mary K.,Chan Gary M.,Elsheikh Bakri,Simard Louise R.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Spinal muscular atrophies: recent insights and impact on molecular diagnosis.;C Brahe;J Mol Med,1996

2. The genetic component in child mortality.;DF Roberts;Arch Dis Child,1970

3. Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.;J Pearn;J Med Genet,1978

4. A hungarian study on Werdnig-Hoffmann disease.;A Czeizel;J Med Genet,1989

5. Population frequencies of inherited neuromuscular diseases–a world survey.;AE Emery;Neuromuscul Disord,1991

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Motor Neurons in Spinal Muscular Atrophy: A Focus on Neuromuscular Junction;International Journal of Molecular Sciences;2024-07-03

2. Neurophysiological and imaging biomarkers of lower motor neuron dysfunction in motor neuron diseases/amyotrophic lateral sclerosis: IFCN handbook chapter;Clinical Neurophysiology;2024-06

3. Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era;Frontiers in Neurology;2023-11-13

4. Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment;International Journal of Molecular Sciences;2023-07-26

5. Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with Nusinersen;Journal of Neuromuscular Diseases;2023-07-04